These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 2625454)
1. Studies on anabolic steroids. III. Detection and characterization of stanozolol urinary metabolites in humans by gas chromatography-mass spectrometry. Massé R; Ayotte C; Bi HG; Dugal R J Chromatogr; 1989 Dec; 497():17-37. PubMed ID: 2625454 [TBL] [Abstract][Full Text] [Related]
2. Metabolism of stanozolol: identification and synthesis of urinary metabolites. Schänzer W; Opfermann G; Donike M J Steroid Biochem; 1990 Jun; 36(1-2):153-74. PubMed ID: 2362445 [TBL] [Abstract][Full Text] [Related]
3. Expanding analytical possibilities concerning the detection of stanozolol misuse by means of high resolution/high accuracy mass spectrometric detection of stanozolol glucuronides in human sports drug testing. Schänzer W; Guddat S; Thomas A; Opfermann G; Geyer H; Thevis M Drug Test Anal; 2013; 5(11-12):810-8. PubMed ID: 23873860 [TBL] [Abstract][Full Text] [Related]
4. Detection of stanozolol O- and N-sulfate metabolites and their evaluation as additional markers in doping control. Balcells G; Matabosch X; Ventura R Drug Test Anal; 2017 Jul; 9(7):1001-1010. PubMed ID: 27714936 [TBL] [Abstract][Full Text] [Related]
5. Detection of stanozolol and its metabolites in equine urine by liquid chromatography-electrospray ionization ion trap mass spectrometry. McKinney AR; Suann CJ; Dunstan AJ; Mulley SL; Ridley DD; Stenhouse AM J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Nov; 811(1):75-83. PubMed ID: 15458725 [TBL] [Abstract][Full Text] [Related]
6. Studies on anabolic steroids--12. Epimerization and degradation of anabolic 17 beta-sulfate-17 alpha-methyl steroids in human: qualitative and quantitative GC/MS analysis. Bi H; Massé R J Steroid Biochem Mol Biol; 1992 Jun; 42(5):533-46. PubMed ID: 1616883 [TBL] [Abstract][Full Text] [Related]
7. Metabolism of stanozolol: chemical synthesis and identification of a major canine urinary metabolite by liquid chromatography-electrospray ionisation ion trap mass spectrometry. Stewart RT; McKinney AR; Kerwick CM; Young EB; Vadasz A; Cade IA; Willis AC; McLeod MD J Steroid Biochem Mol Biol; 2009 Nov; 117(4-5):152-8. PubMed ID: 19748583 [TBL] [Abstract][Full Text] [Related]
8. The application of in vitro technologies to study the metabolism of the androgenic/anabolic steroid stanozolol in the equine. Scarth JP; Spencer HA; Hudson SC; Teale P; Gray BP; Hillyer LL Steroids; 2010 Jan; 75(1):57-69. PubMed ID: 19854209 [TBL] [Abstract][Full Text] [Related]
9. Long-term detection and identification of metandienone and stanozolol abuse in athletes by gas chromatography-high-resolution mass spectrometry. Schänzer W; Delahaut P; Geyer H; Machnik M; Horning S J Chromatogr B Biomed Appl; 1996 Dec; 687(1):93-108. PubMed ID: 9001957 [TBL] [Abstract][Full Text] [Related]
10. Gas chromatographic-mass spectrometric identification of main metabolites of stanozolol in cattle after oral and subcutaneous administration. Ferchaud V; Le Bizec B; Montrade MP; Maume D; Monteau F; André F J Chromatogr B Biomed Sci Appl; 1997 Aug; 695(2):269-77. PubMed ID: 9300863 [TBL] [Abstract][Full Text] [Related]
11. Complementing the characterization of in vivo generated N-glucuronic acid conjugates of stanozolol by collision cross section computation and analysis. Thevis M; Dib J; Thomas A; Höppner S; Lagojda A; Kuehne D; Sander M; Opfermann G; Schänzer W Drug Test Anal; 2015; 7(11-12):1050-6. PubMed ID: 26514814 [TBL] [Abstract][Full Text] [Related]
12. Detection and structural investigation of metabolites of stanozolol in human urine by liquid chromatography tandem mass spectrometry. Pozo OJ; Van Eenoo P; Deventer K; Lootens L; Grimalt S; Sancho JV; Hernández F; Meuleman P; Leroux-Roels G; Delbeke FT Steroids; 2009 Oct; 74(10-11):837-52. PubMed ID: 19464304 [TBL] [Abstract][Full Text] [Related]
13. Studies on anabolic steroids. I. Integrated methodological approach to the gas chromatographic-mass spectrometric analysis of anabolic steroid metabolites in urine. Massé R; Ayotte C; Dugal R J Chromatogr; 1989 Apr; 489(1):23-50. PubMed ID: 2663904 [TBL] [Abstract][Full Text] [Related]
14. Studies on anabolic steroids. II--Gas chromatographic/mass spectrometric characterization of oxandrolone urinary metabolites in man. Massé R; Bi HG; Ayotte C; Dugal R Biomed Environ Mass Spectrom; 1989 Jun; 18(6):429-38. PubMed ID: 2765703 [TBL] [Abstract][Full Text] [Related]
15. N-isobutyloxycarbonylation for improved detection of 3'-hydroxystanozolol and its 17-epimer in doping control. Choi MH; Chung BC Analyst; 2001 Mar; 126(3):306-9. PubMed ID: 11284331 [TBL] [Abstract][Full Text] [Related]
16. Ultra high performance liquid chromatography tandem mass spectrometry determination and profiling of prohibited steroids in human biological matrices. A review. Gosetti F; Mazzucco E; Gennaro MC; Marengo E J Chromatogr B Analyt Technol Biomed Life Sci; 2013 May; 927():22-36. PubMed ID: 23317577 [TBL] [Abstract][Full Text] [Related]
17. A novel HPLC-MRM strategy to discover unknown and long-term metabolites of stanozolol for expanding analytical possibilities in doping-control. Wang Z; Zhou X; Liu X; Dong Y; Zhang J J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Jan; 1040():250-259. PubMed ID: 27842983 [TBL] [Abstract][Full Text] [Related]
18. Quantitative determination of stanozolol and its metabolite in urine by gas chromatography/mass spectrometry. Choo HY; Kwon OS; Park J J Anal Toxicol; 1990; 14(2):109-12. PubMed ID: 2325376 [TBL] [Abstract][Full Text] [Related]
19. Analytical challenges in doping control: Comprehensive two-dimensional gas chromatography with time of flight mass spectrometry, a promising option. Silva AI; Pereira HM; Casilli A; Conceição FC; Aquino Neto FR J Chromatogr A; 2009 Apr; 1216(14):2913-22. PubMed ID: 19013575 [TBL] [Abstract][Full Text] [Related]
20. Multi-laboratory study of the analysis and kinetics of stanozolol and its metabolites in treated calves. De Brabander HF; De Wasch K; van Ginkel LA; Sterk SS; Blokland MH; Delahaut P; Taillieu X; Dubois M; Arts CJ; van Baak MJ; Gramberg LG; Schilt R; van Bennekom EO; Courtheyn D; Vercammen J; Witkamp RF Analyst; 1998 Dec; 123(12):2599-604. PubMed ID: 10435307 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]